Pulmozyme is contraindicated in patients with hypersensitivity to dornase alfa, Chinese Hamster Ovary (CHO) cell products, or formulation excipients.
Key precautions include strict adherence to nebulizer compatibility (e.g., avoiding masks with eRapid® for pediatric patients) and avoiding drug mixing. Storage mandates refrigeration (2°C–8°C) in protective foil; exposure to room temperature >60 hours invalidates use. Pediatric safety is established for ages ≥3 months, but geriatric data are lacking. No warnings for drug interactions or teratogenicity exist, though pregnancy/lactation data remain limited. Device maintenance (cleaning, disinfection) per manufacturer guidelines is critical to prevent contamination.

